Improved survival of patients with newly diagnosed oligometastatic prostate cancer through intensified multimodal treatment
An intensified, multimodal treatment approach including RP can lead to excellent survival outcomes in patients with newly diagnosed omPCa. Patients requiring chemotherapy have most likely a more aggressive disease and therefore a more rapid tumor progression. Future studies to identify markers for risk stratification in patients with omPCa are therefore needed.
Authors
- Stefanie Zschäbitz (ORCID: https://orcid.org/0000-0001-8917-3263)
- Markus Hohenfellner (ORCID: https://orcid.org/0000-0003-3798-2039)
- Anette Duensing (ORCID: https://orcid.org/0000-0002-0168-4067)
- Viktoria Schütz
- Jürgen Debus
- Dirk Jäger
- Christopher-Leo Nessler
Institutions
- Heidelberg University (DE)
- University Hospital Heidelberg (DE)
- National Center for Tumor Diseases (DE)
Publication Details
- Journal
- Frontiers in Oncology
- Published
- 2024-12-10
- DOI
- https://doi.org/10.3389/fonc.2024.1475914
- Citations
- 1
- Primary Topic
- Prostate Cancer Treatment and Research
- Type
- article
- Field-Weighted Citation Impact
- 0.42